| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| June 23rd, 2008 | 29 | Yes |
Popular Name: N,N-dimethyl-2-[4-[4-[3-(2-pyridyl)-1H-pyrazol-4-yl]-2-pyridyl]phenoxy]ethanamine N,N-dimethyl-2-[4-[4-[3-(2-pyrid…
None
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.26 | 10.38 | -45.12 | 2 | 6 | 1 | 68 | 386.479 | 7 | ↓ |
| Hi High (pH 8-9.5) | 3.26 | 7.79 | -12.47 | 1 | 6 | 0 | 67 | 385.471 | 7 | ↓ |
| Lo Low (pH 4.5-6) | 3.26 | 10.57 | -78.38 | 3 | 6 | 2 | 69 | 387.487 | 7 | ↓ |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| TGFB1-1-E | Transforming Growth Factor Beta-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 19 | 0.37 | Binding ≤ 10μM |
| TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 15 | 0.38 | Binding ≤ 10μM |
| Z81020-3-O | HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other | Other | 14 | 0.38 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 15 | 0.38 | Binding ≤ 1μM |
| TGFB1_HUMAN | P01137 | Transforming Growth Factor Beta-1, Human | 19 | 0.37 | Binding ≤ 1μM |
| TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 15 | 0.38 | Binding ≤ 10μM |
| TGFB1_HUMAN | P01137 | Transforming Growth Factor Beta-1, Human | 19 | 0.37 | Binding ≤ 10μM |
| Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 14 | 0.38 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Downregulation of TGF-beta receptor signaling | |
| ECM proteoglycans | |
| Influenza Virus Induced Apoptosis | |
| Molecules associated with elastic fibres | |
| Platelet degranulation | |
| SMAD2/3 MH2 Domain Mutants in Cancer | |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
| Syndecan interactions | |
| TGF-beta receptor signaling activates SMADs | |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
| TGFBR1 KD Mutants in Cancer | |
| TGFBR1 LBD Mutants in Cancer | |
| TGFBR2 Kinase Domain Mutants in Cancer | |
| TGFBR2 MSI Frameshift Mutants in Cancer | |
| Transcriptional regulation of white adipocyte differentiation |
No pre-computed analogs available. Try a structural similarity search.